During the past decade, SSM Health Cancer Care conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "SSM Health Cancer Care" are "Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma" (1 trials), "Mantle Cell Lymphoma" (1 trials), "Marginal Zone Lymphoma" (1 trials), "Metastatic Cancer" (1 trials) and "Waldenstrom Macroglobulinemia" (1 trials). Many other conditions were trialed in "SSM Health Cancer Care" in a lesser frequency.

Most popular intervention types in "SSM Health Cancer Care" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Nivolumab Extended" (1 trials), "Nivolumab Standard" (1 trials), "Pembrolizumab Extended" (1 trials), "Pembrolizumab Standard" (1 trials) and "Zanubrutinib" (1 trials). Other intervention names were less common.

The vast majority of trials in "SSM Health Cancer Care" are 2 trials for "All" genders.

Currently, there are NaN active trials in "SSM Health Cancer Care". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in SSM Health Cancer Care, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in SSM Health Cancer Care, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".